Related Experiment Video
Updated: May 13, 2026
High Yield Purification of Plasmodium falciparum Merozoites For Use in Opsonizing Antibody Assays
Published on: July 17, 2014
Young lives lost as B cells falter: what we are learning about antibody responses in malaria
Silvia Portugal1, Susan K Pierce, Peter D Crompton
1Laboratory of Immunogenetics, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA.
Insights
Despite Plasmodium falciparum malaria vaccine development challenges, understanding B cell responses is key. Research highlights infection-induced B cell dysregulation, suggesting new vaccine strategies against malaria.
Area of Science:
- Immunology
- Infectious Diseases
- Vaccinology
Background:
- Plasmodium falciparum malaria is a significant global health issue with no current vaccine.
- Antibody (Ab)-mediated immunity develops slowly after repeated infections, leaving young children vulnerable.
- Antigen (Ag) diversity and clonally variant antigens in P. falciparum hinder protective Ab acquisition.
Purpose of the Study:
- To review current understanding of B cell biology during P. falciparum infection.
- To explore how B cell function dysregulation impacts malaria immunity.
- To identify potential new avenues for effective malaria vaccine development.
Main Methods:
- Review of population-based studies from malaria-endemic regions.
- Analysis of immunological data on B cell responses to P. falciparum.
- Integration of findings with advances in immunology and genomics.
Main Results:
- P. falciparum infection can lead to dysregulation of B cell function, beyond Ag diversity.
- Understanding B cell biology is crucial for explaining slow acquisition of protective immunity.
- Existing studies provide a foundation for further research into B cell responses.
Conclusions:
- Developing effective malaria vaccines requires a deeper understanding of B cell responses and potential dysregulation.
- Advances in immunology and genomics can enhance our knowledge of B cell biology in malaria.
- Targeting B cell pathways may offer novel strategies for P. falciparum vaccine development.
Abstract:
Plasmodium falciparum malaria remains a major public health threat for which there is no licensed vaccine. Abs play a key role in malaria immunity, but Ab-mediated protection is only acquired after years of repeated infections, leaving children in endemic areas vulnerable to severe malaria and death. Many P. falciparum Ags are extraordinarily diverse and clonally variant, which likely contribute to the inefficient acquisition of protective Abs. However, mounting evidence suggests that there is more to the story and that infection-induced dysregulation of B cell function also plays a role. We herein review progress toward understanding the B cell biology of P. falciparum infection, focusing on what has been learned from population-based studies in malaria-endemic areas. We suggest ways in which advances in immunology and genomics-based technology can further improve our understanding of the B cell response in malaria and perhaps illuminate new pathways to the development of effective vaccines.
Related Concept Videos
01:36Humoral Immune Responses
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
01:23Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
01:40Cell-mediated Immune Responses
01:23Cells of the Adaptive Immune Response